← Product Code [CBF](/submissions/AN/subpart-f%E2%80%94therapeutic-devices/CBF) · K041007

# MILLENIUM, MODELS 2000, 2001 AND 2002 (K041007)

_Hyperbaric For Life, LLC · CBF · Nov 15, 2004 · Anesthesiology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/AN/subpart-f%E2%80%94therapeutic-devices/CBF/K041007

## Device Facts

- **Applicant:** Hyperbaric For Life, LLC
- **Product Code:** [CBF](/submissions/AN/subpart-f%E2%80%94therapeutic-devices/CBF.md)
- **Decision Date:** Nov 15, 2004
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 868.5470
- **Device Class:** Class 2
- **Review Panel:** Anesthesiology
- **Attributes:** Therapeutic

## Indications for Use

The conditions listed as appropriate for the use of Hyperbaric Oxygen Therapy in the current Undersea and Hyperbaric Medical Society (UHMS) Hyperbaric Oxygen Therapy Committee Report (1998) are as follows: Air or gas embolism; Carbon monoxide poisoning and carbon monoxide poisoning complicated by cyanide poisoning; Clostridial myositis and myonecrosis; Crush injury, compartment syndrome, and other acute traumatic ischemias; Decompression sickness; Enhanced healing of selected problem wounds; Exceptional blood loss anemia; Necrotizing soft tissue infections; Osteomyelitis (refractory); Delayed radiation injury (soft tissue and bone necrosis); Skin grafts and flaps (compromised); Thermal burns; Intracranial abscess.

## Device Story

Millennium 2000-2005 series are hyperbaric chambers designed for hyperbaric oxygen therapy. Device provides pressurized environment to deliver oxygen to patients. Used in clinical settings under physician supervision. Benefits include treatment of conditions like decompression sickness, carbon monoxide poisoning, and wound healing. Operation involves patient placement within chamber, pressurization, and oxygen administration per UHMS guidelines.

## Clinical Evidence

No clinical data provided; substantial equivalence based on regulatory classification and adherence to UHMS 1998 guidelines for hyperbaric oxygen therapy indications.

## Technological Characteristics

Hyperbaric chamber (Class II, Product Code CBF). Operates under 21 CFR 868.5470. Technical specifications and materials not detailed in provided documentation.

## Regulatory Identification

A hyperbaric chamber is a device that is intended to increase the environmental oxygen pressure to promote the movement of oxygen from the environment to a patient's tissue by means of pressurization that is greater than atmospheric pressure. This device does not include topical oxygen chambers for extremities (§ 878.5650).

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image is a circular seal for the Department of Health & Human Services - USA. The seal features the department's logo, which consists of three stylized wavy lines, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the logo in a circular fashion. The text is in all caps and is evenly spaced around the circle.

## Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

NOV 1 5 2004

Mr. Rick Ryder Owner Hyperbaric for Life, LLC 3206 West State Avenue Phoenix, Arizona 85051

Re: K041007

Trade/Device Name: Millennium 2000, 2001, 2002, 2003, 2004, 2005 Regulation Number: 868.5470 Regulation Name: Hyperbaric Chamber Regulatory Class: II Product Code: CBF Dated: October 25, 2004 Received: October 25, 2004

Dear Mr. Ryder:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Page 2 - Mr. Ryder

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Carls

Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Section 2

Indications for Use

(To be assigned) K 041007 _____________________________________________________________________________________________________________________________________________________________________ 510(k) Number:

Millennium 2000,2001,2002,2003,2004,2005 Device Name:

## Indications for Use:

The conditions listed as appropriate for the use of Hyperbaric Oxygen Therapy in the current The conditions instou as upprophato sic and Medical Society (UHMS)Hyperbaric Oxygen Therapy Committee Report (1998) are as follows

Air or gas embolism

Carbon monoxide poisoning and carbon monoxide poisoning complicated by cyanide poisoning

or

Clostridial myositis and myonecrosis

Crush injury, compartment syndrome, and other acute traumatic ischemias

Decompression sickness

Enhanced healing of selected problem wounds

Exceptional blood loss anemia

Necrotizing soft tissue infections

Osteomyelitis (refractory)

Delayed radiation injury ( soft tissue and bone necrosis)

Skin grafts and flaps (compromised)

Thermal burns

Intracranial abscess

Prescription Use X (Per CFR 801.109)

Wigin

(Division Sign-Off) (Division Sign-Off)
Division of Anesthesiology, General Hospital, Division of Anton Dental Devices KO41007

510(k) Number:_

Over-the-counter use __

12

---

**Source:** [https://fda.innolitics.com/submissions/AN/subpart-f%E2%80%94therapeutic-devices/CBF/K041007](https://fda.innolitics.com/submissions/AN/subpart-f%E2%80%94therapeutic-devices/CBF/K041007)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com